SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-019073
Filing Date
2023-05-25
Accepted
2023-05-25 16:05:31
Documents
12
Period of Report
2023-05-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39321
  Complete submission text file 0001493152-23-019073.txt   209614

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE indp-20230525.xsd EX-101.SCH 2965
3 XBRL LABEL FILE indp-20230525_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE indp-20230525_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3383
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 23960427
SIC: 2834 Pharmaceutical Preparations